Annual report pursuant to Section 13 and 15(d)

Note 15 - Income Taxes - Deferred Tax Assets and Liabilities (Details)

v3.23.1
Note 15 - Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Non-capital losses carried forward $ 21,000 $ 17,596
Research and development expenditures 817 817
Share issue costs 338 608
Patents and other 320 309
Accruals 213 76
Share-based compensation 166 0
Property and equipment (117) (13)
Total deferred tax asset, net 22,737 19,393
Valuation allowance (22,737) (19,393)
Net deferred tax asset $ 0 $ 0